IQI
AMED

Integrated Quantitative Investments’s Amedisys AMED Stock Holding History

Integrated Quantitative Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,605
Closed -$945K – 353
2025
Q2 		$945K Buy
+9,605
New +$909K 0.28% 148

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Integrated Quantitative Investments's AMED Position: Q3 2025 in Review

Integrated Quantitative Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,605 shares — an estimated $945K sold.

Integrated Quantitative Investments first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $945K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Integrated Quantitative Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 9,605 Amedisys shares in Q3 2025, an estimated $945K.
  • Integrated Quantitative Investments first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Integrated Quantitative Investments's Amedisys position peaked at $945K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Integrated Quantitative Investments's 13F filing for Q3 2025, filed 12 Nov 2025.